A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease. The AI model, known as ImmunoMatch, can predict and identify correct protein ...

Two-Stage Hierarchical Pre-training Framework of S 2 ALM: In Stage I, the model learns foundational sequence–structure relationships from large-scale protein data, using 1D amino acid sequences and 3D ...

A recent study published in PLOS Computational Biology designed immunogens to induce antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Study: Design of ...

(A) Cryo-EM structure overview of HSV-1 gB in complex with D48 Fab. The side view and top view were presented. The HSV-1 gB trimer and D48 Fab VH/VL were colored differently. (B) Neutralization assay ...

A novel computational framework revolutionizes antibody design, offering precise predictions and unlocking insights into the immune system’s structural and functional convergence. Study: Learning the ...

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelligence, today announced ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is advancing Bio-Native™ AI at the intersection of biology and computation. The Company’s LENSai™ and HYFT® platforms enable large-scale reasoning across ...